USRD:NASDAQThemes US R&D Champions ETF Analysis
Data as of 2026-05-07 - not real-time
$36.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The ETF trades at $35.995, just 0.6% below its 52‑week high of $36.206, sitting above its 20‑day SMA (34.40) and 50‑day SMA (33.07), indicating short‑term momentum. The MACD line (0.84) remains above its signal (0.70), generating a bullish signal, while the RSI sits at 68.7, approaching overbought territory. Volume is on an increasing trend despite low absolute numbers, supporting the price advance. The fund’s beta of 1.21 and 30‑day volatility of 22.6% point to higher market sensitivity and price swings. The Fear & Greed Index at 90.93 signals “Extreme Greed,” suggesting bullish sentiment may be overstretched.
However, the ETF’s small asset base (~$1.0 M) and average daily volume (~190 shares) create a high liquidity risk, and the thematic focus on U.S. R&D champions implies a concentrated sector exposure. The max drawdown of 13.9% and the neutral longer‑term trend underscore the need for caution. With a modest expense ratio of 0.29% and zero tracking error, the fund offers cost‑effective exposure but investors should monitor volatility. Overall, the technical picture is supportive, yet the structural constraints temper enthusiasm.
However, the ETF’s small asset base (~$1.0 M) and average daily volume (~190 shares) create a high liquidity risk, and the thematic focus on U.S. R&D champions implies a concentrated sector exposure. The max drawdown of 13.9% and the neutral longer‑term trend underscore the need for caution. With a modest expense ratio of 0.29% and zero tracking error, the fund offers cost‑effective exposure but investors should monitor volatility. Overall, the technical picture is supportive, yet the structural constraints temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near 52‑week high with bullish MACD
- RSI approaching overbought
- increasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- sustained above‑average SMA levels
- thematic exposure to growing R&D spend
- low expense ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- potential long‑term innovation tailwinds
- cost‑efficient structure
- absence of tracking error
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.29%
AUM$1.0M
Inception Date2023-12-12
Avg Daily Volume190
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.40%
Technical Analysis
TrendNeutral
RSI68.7
Support$31.98
Resistance$36.21
MA 20$34.40
MA 50$33.07
MA 200$33.26
MACDBullish
VolumeIncreasing
Fear & Greed Index90.93
Risk Assessment
Beta1.21
Volatility22.64%
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.